UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (1), p.329-337

2009

Volltextzugriff (PDF)

Factors Influencing Family Burden in Pediatric Hematology/Oncology Encounters

Journal of patient-centered research and reviews, 2019-10, Vol.6 (4), p.243-251

2019

Volltextzugriff (PDF)

Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma

Molecular cancer therapeutics, 2009-08, Vol.8 (8), p.2461-2469

2009

Volltextzugriff (PDF)

Asparaginase products in upfront acute lymphoblastic leukemia therapy: Value, location, and style

Pediatric blood & cancer, 2019-01, Vol.66 (1), p.e27497-n/a

Russell, Heidi V.

2019

Volltextzugriff (PDF)

Interleukin-6 and Soluble Interleukin-6 Receptor Levels as Markers of Disease Extent and Prognosis in Neuroblastoma

Clinical cancer research, 2008-11, Vol.14 (21), p.7028-7034

2008

Volltextzugriff (PDF)

Clinical Application of Genome and Exome Sequencing as a Diagnostic Tool for Pediatric Patients: a Scoping Review of the Literature

Genetics in medicine, 2019-01, Vol.21 (1), p.3-16

2019

Volltextzugriff (PDF)

Healthcare Spending and Systemic Bevacizumab for Recurrent Respiratory Papillomatosis

Journal of voice, 2024-04

2024

Volltextzugriff (PDF)

Using the Delphi method to identify clinicians' perceived importance of pediatric exome sequencing results

Genetics in medicine, 2020-01, Vol.22 (1), p.69-76

2020

Volltextzugriff (PDF)

US private payers’ perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER)

Genetics in medicine, 2022-01, Vol.24 (1), p.238-244

2022

Volltextzugriff (PDF)

Exome sequencing compared with standard genetic tests for critically ill infants with suspected genetic conditions

Genetics in medicine, 2020-08, Vol.22 (8), p.1303-1310

2020

Volltextzugriff (PDF)

Using decision modeling to guide drug allocation during a shortage

Pediatric blood & cancer, 2017-07, Vol.64 (7), p.n/a

2017

Volltextzugriff (PDF)

Diagnostic and therapeutic role of endoscopic retrograde cholangiopancreatography in biliary rhabdomyosarcoma

World journal of gastroenterology : WJG, 2008-08, Vol.14 (30), p.4823-4825

2008

Volltextzugriff (PDF)

Treatment of nasopharyngeal carcinoma with Epstein-Barr virus–specific T lymphocytes

Blood, 2005-03, Vol.105 (5), p.1898-1904

2005

Volltextzugriff (PDF)

Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastoma

Molecular cancer therapeutics, 2009-08, Vol.8 (8), p.2478-2489

2009

Volltextzugriff (PDF)

Creating a Clinical Systems Integration Strategy to Drive Improvement

Current treatment options in pediatrics, 2015-12, Vol.1 (4), p.334-346

2015

Volltextzugriff (PDF)

A Clinical and Sociodemographic Risk Prediction Model Evaluating Adherence to Long-Term Care in Survivors of Childhood Leukemia

Blood, 2022-11, Vol.140 (Supplement 1), p.5236-5237

2022

Volltextzugriff (PDF)

Neuroblastoma-derived secretory protein messenger RNA levels correlate with high-risk neuroblastoma

Journal of pediatric surgery, 2007, Vol.42 (1), p.148-152

2007

Volltextzugriff (PDF)

Rising Drug Cost Impacts on Cost-Effectiveness of Two Chemotherapy Regimens for Intermediate Risk Rhabdomyosarcoma: A Report from the Children’s Oncology Group

Cancer, 2021-10, Vol.128 (2), p.317-325

2021

Volltextzugriff (PDF)

Patched haploinsufficient mouse rhabdomyosarcoma overexpress secreted phosphoprotein 1 and matrix metalloproteinases

European journal of cancer (1990), 2007-05, Vol.43 (8), p.1308-1317

2007

Volltextzugriff (PDF)

Using decision modeling to guide drug allocation during a shortage: R ussell et al

Pediatric blood & cancer, 2017-07, Vol.64 (7), p.e26331

2017

Volltextzugriff (PDF)

Interleukin-6 and soluble IL-6 receptor levels as markers of disease extent and prognosis in neuroblastoma

Clinical cancer research, 2008-11, Vol.14 (21), p.7028-7034

2008

Volltextzugriff (PDF)

Interieukin-6 in the Bone Marrow Microenvironment Promotes the Growth and Survival of Neuroblastoma Cells

Cancer research (Chicago, Ill.), 2009, Vol.69 (1), p.329-337

2009

Volltextzugriff (PDF)

Diaanostic and therapeutic role of endoscopic retrograde cholangiopancreatography in biliary rhabdomyosarcoma

世界胃肠病学杂志（英文版）, 2008, Vol.14 (30), p.4823-4825

2008

Volltextzugriff (PDF)

Neuroblastoma

Adrenal Glands, p.211-222

Volltextzugriff (PDF)

Estimating the cost of Rh testing and prophylaxis in early pregnancy: A time-driven activity-based costing study

Contraception (Stoneham), 2024-08, Vol.136, p.110468, Article 110468

2024

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Aktive Filter

ThemaChild

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(52)

Publikationsform

Sprache

Englisch
(58)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells

Factors Influencing Family Burden in Pediatric Hematology/Oncology Encounters

Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma

Asparaginase products in upfront acute lymphoblastic leukemia therapy: Value, location, and style

Interleukin-6 and Soluble Interleukin-6 Receptor Levels as Markers of Disease Extent and Prognosis in Neuroblastoma

Clinical Application of Genome and Exome Sequencing as a Diagnostic Tool for Pediatric Patients: a Scoping Review of the Literature

Healthcare Spending and Systemic Bevacizumab for Recurrent Respiratory Papillomatosis

Using the Delphi method to identify clinicians' perceived importance of pediatric exome sequencing results

US private payers’ perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER)

Exome sequencing compared with standard genetic tests for critically ill infants with suspected genetic conditions

Using decision modeling to guide drug allocation during a shortage

Diagnostic and therapeutic role of endoscopic retrograde cholangiopancreatography in biliary rhabdomyosarcoma

Treatment of nasopharyngeal carcinoma with Epstein-Barr virus–specific T lymphocytes

Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastoma

Creating a Clinical Systems Integration Strategy to Drive Improvement

A Clinical and Sociodemographic Risk Prediction Model Evaluating Adherence to Long-Term Care in Survivors of Childhood Leukemia

Neuroblastoma-derived secretory protein messenger RNA levels correlate with high-risk neuroblastoma

Rising Drug Cost Impacts on Cost-Effectiveness of Two Chemotherapy Regimens for Intermediate Risk Rhabdomyosarcoma: A Report from the Children’s Oncology Group

Patched haploinsufficient mouse rhabdomyosarcoma overexpress secreted phosphoprotein 1 and matrix metalloproteinases

Using decision modeling to guide drug allocation during a shortage: R ussell et al

Interleukin-6 and soluble IL-6 receptor levels as markers of disease extent and prognosis in neuroblastoma

Interieukin-6 in the Bone Marrow Microenvironment Promotes the Growth and Survival of Neuroblastoma Cells

Diaanostic and therapeutic role of endoscopic retrograde cholangiopancreatography in biliary rhabdomyosarcoma

Neuroblastoma

Estimating the cost of Rh testing and prophylaxis in early pregnancy: A time-driven activity-based costing study

Aktive Filter

Suchergebnisse filtern